Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner.
Loukili
Noureddine
N
Department of Intensive Care Medicine, Division of Pathophysiology, Faculty of Biology and Medicine, University MedicalCenter, 1011 Lausanne, Switzerland.
Rosenblatt-Velin
Nathalie
N
Rolli
Joëlle
J
Levrand
Sandra
S
Feihl
François
F
Waeber
Bernard
B
Pacher
Pal
P
Liaudet
Lucas
L
D000818:Animals; D045744:Cell Line, Tumor; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology*; D051550:I-kappa B Kinase / Q000378:metabolism; D020672:I-kappa B Proteins / Q000378:metabolism; D007249:Inflammation / Q000378:metabolism; D053583:Interleukin-1beta / Q000378:metabolism; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism*; D016877:Oxidants / Q000494:pharmacology*; D030421:Peroxynitrous Acid / Q000494:pharmacology*; D010766:Phosphorylation / Q000187:drug effects; D054648:Protein Phosphatase 2 / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D020672:I-kappa B Proteins; D053583:Interleukin-1beta; D016328:NF-kappa B; D016877:Oxidants; D014409:Tumor Necrosis Factor-alpha; D030421:Peroxynitrous Acid; D006861:Hydrogen Peroxide; D051550:I-kappa B Kinase; D054648:Protein Phosphatase 2